Home monitoring in interstitial lung diseases

Marlies S Wijsenbeek; Catharina C Moor; Kerri A Johannson; Peter D Jackson; Yet H Khor; Yasuhiro Kondoh; Sujeet K Rajan; Gabriela C Tabaj; Brenda E Varela; Pieter van der Wal; Richard N van Zyl-Smit; Michael Kreuter; Toby M Maher

doi:10.1016/S2213-2600(22)00228-4

Home monitoring in interstitial lung diseases

Lancet Respir Med. 2023 Jan;11(1):97-110. doi: 10.1016/S2213-2600(22)00228-4. Epub 2022 Oct 4.

Authors

Affiliations

¹ Centre of Excellence for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands. Electronic address: m.wijsenbeek-lourens@erasmusmc.nl.
² Centre of Excellence for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
³ Department of Medicine and Snyder Institute for Chronic Diseases, University of Calgary, Calgary, AB, Canada.
⁴ Department of Pulmonary and Critical Care Medicine, Virginia Commonwealth University, Richmond, VA, USA.
⁵ Central Clinical School, Monash University, Melbourne, VIC, Australia; Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, VIC, Australia.
⁶ Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.
⁷ Department of Chest Medicine, Bombay Hospital Institute of Medical Sciences, Bhatia Hospital, Mumbai, India.
⁸ Department of Respiratory Medicine, Cetrángolo Hospital, Buenos Aires, Argentina.
⁹ Department of Respiratory Medicine, Hospital Alemán, Buenos Aires, Argentina.
¹⁰ Patient expert, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
¹¹ Division of Pulmonology and University of Cape Town Lung Institute, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
¹² Center for Interstitial and Rare Lung Diseases and Interdisciplinary Center for Sarcoidosis, Thoraxklinik, University Hospital Heidelberg, Germany; German Center for Lung Research, Heidelberg, Germany; Department of Pneumology, RKH Clinics Ludwigsburg, Ludwigsburg, Germany.
¹³ Division of Pulmonary, Critical Care and Sleep Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; National Heart and Lung Institute, Imperial College London, London, UK.

PMID: 36206780
DOI: 10.1016/S2213-2600(22)00228-4

Abstract

The widespread use of smartphones and the internet has enabled self-monitoring and more hybrid-care models. The COVID-19 pandemic has further accelerated remote monitoring, including in the heterogenous and often vulnerable group of patients with interstitial lung diseases (ILDs). Home monitoring in ILD has the potential to improve access to specialist care, reduce the burden on health-care systems, improve quality of life for patients, identify acute and chronic disease worsening, guide treatment decisions, and simplify clinical trials. Home spirometry has been used in ILD for several years and studies with other devices (such as pulse oximeters, activity trackers, and cough monitors) have emerged. At the same time, challenges have surfaced, including technical, analytical, and implementational issues. In this Series paper, we provide an overview of experiences with home monitoring in ILD, address the challenges and limitations for both care and research, and provide future perspectives. VIDEO ABSTRACT.

Publication types

Video-Audio Media
Review

MeSH terms

COVID-19*
Humans
Lung Diseases, Interstitial* / diagnosis
Lung Diseases, Interstitial* / therapy
Oxygen
Pandemics
Quality of Life

Substances

Oxygen